Prenatal Genetic Testing Market Report 2024 (Global Edition)

Global Prenatal Genetic Testing Market Report 2024 Market Size Split by Technology (Diagnostics Methods, Polymerase Chain Reaction, Array Comparative Genomic Hybridization (Acgh), Fluorescence In Situ...

Prenatal Genetic Testing Market Report Description

We have various report editions of Prenatal Genetic Testing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Prenatal Genetic Testing Market Insights Video

Competitive Landscape of the Prenatal Genetic Testing Market

The competitive landscape of the Prenatal Genetic Testing Market is characterized by a diverse range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include the genetics market, specialized hospitals, and emerging start-ups aiming to disrupt the market with innovative solutions.

In April 2024, FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer. Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage resected non-small cell lung cancer.

(Source: https://www.roche.com/media/releases/med-cor-2024-04-19/)

Top Companies Market Share in Prenatal Genetic Testing Industry: (In no particular order of Rank)

• Abbott (U.S.)
• Siemens Healthineers AG (Germany)
• Quidel Corporation (U.S.)
• F. Hoffman-La Roche Ltd. (Switzerland)
• Danaher. (U.S.)
• B.D. (U.S.)
• Chembio Diagnostics (U.S.)
• Trinity Biotech plc (Ireland)
• Instrumentation Laboratory (U.S.)
• Nova Biomedical (U.S.)
• PTS Diagnostics (U.S.)
• Sekisui Diagnostics (U.S.)
• Thermo Fisher Scientific (U.S.)
• DiaSorin S.p.A (Italy)
• AccuBioTech Co.
• Ltd. (China)
• Meridian Bioscience (U.S.)
• GeneSTAT Molecular Diagnostics
• LLC (U.S.)
• Terumo Corporation (Japan)
• Grifols
• S.A (Spain)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of Prenatal Genetic Testing Market.

Which Region dominates the Prenatal Genetic Testing Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. This significant market presence can be attributed to several factors, including robust healthcare infrastructure, advanced technological capabilities, and a high level of awareness among both healthcare professionals and the general population regarding the benefits of genetic testing during pregnancy. The region's well-established regulatory framework and supportive government policies have fostered an environment conducive to the growth of the prenatal genetic testing market.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific stands out as the fastest-growing region in the Prenatal Genetic Testing Market due to several compelling reasons. Rapid urbanization, increasing disposable income, and improving healthcare infrastructure are expanding access to prenatal care and genetic testing services across the region. Furthermore, rising awareness about the importance of early detection and management of genetic disorders, coupled with a growing emphasis on preventive healthcare, is driving demand for prenatal genetic testing.

 

The current report Scope analyzes Prenatal Genetic Testing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

North America Prenatal Genetic Testing

According to Cognitive Market Research, the global Prenatal Genetic Testing Market size was estimated at USD 10251.2 Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD 4100.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.2% from 2024 to 2031. 

• According to Cognitive Market Research, the US had a major share in the Prenatal Genetic Testing Market with a market ize of USD 3235.28 million in 2024 and is projected to grow at a CAGR of 13.0% during the forecast period. This growth is attributed to several factors, including increasing maternal age, advancements in technology, and rising awareness among both healthcare professionals and the general population regarding the benefits of genetic testing during pregnancy.
• The Canada Prenatal Genetic Testing Market had a market share of USD 492.06 million in 2024 and is projected to grow at a CAGR of 14.0% during the forecast period. This growth is attributed to several factors, including increasing maternal age, advancements in technology, and rising awareness among both healthcare professionals and the general population regarding the benefits of genetic testing during pregnancy. The
• Mexico Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 13.7% during the forecast period with a market size of USD 373.14 million in 2024.

Europe Prenatal Genetic Testing

According to Cognitive Market Research, the global Prenatal Genetic Testing Market size was estimated at USD 10251.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 3075.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.5% from 2024 to 2031.

• The United Kingdom Prenatal Genetic Testing Market had a market share of USD 516.66 million in 2024 and is projected to grow at a CAGR of 14.3% during the forecast period. This growth is attributed to several factors, including increasing maternal age, advancements in technology, and rising awareness among both healthcare professionals and the general population regarding the benefits of genetic testing during pregnancy.
• The France Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 12.7% during the forecast period with a market size of USD 282.93 million in 2024.
• According to Cognitive Market Research, the Germany Prenatal Genetic Testing Market size was valued at USD 608.92 million in 2024 and is projected to grow at a CAGR of 13.7% during the forecast period. This growth is attributed to several factors, including increasing maternal age, advancements in technology, and rising awareness among both healthcare professionals and the general population regarding the benefits of genetic testing during pregnancy.
• The Italy Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 12.9% during the forecast period with a market size of USD 264.48 million in 2024. The Russia Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 12.5% during the forecast period with a market size of USD 476.68 million in 2024.
• The Spain Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 12.6% during the forecast period with a market size of USD 252.18 million in 2024.
• The Luxembourg Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 13.6% during the forecast period with a market size of USD 95.34 million in 2024. The Portugal Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 13.3% during the forecast period with a market size of USD 64.58 million in 2024.
• The Greece Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 13.8% during the forecast period with a market size of USD 36.90 million in 2024.
• Rest of Europe Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 12.2% during the forecast period with a market size of USD 476.68 in 2024. .

Asia Pacific Prenatal Genetic Testing

According to Cognitive Market Research, the global Prenatal Genetic Testing Market size was estimated at USD 10251.2 Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 2357.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Prenatal Genetic Testing Market size was valued at USD 1061.00 million in 2024 and is projected to grow at a CAGR of 16.5% during the forecast period. This growth is attributed to several factors, including increasing maternal age, advancements in technology, and rising awareness among both healthcare professionals and the general population regarding the benefits of genetic testing during pregnancy.
• The Japan Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 15.5% during the forecast period with a market size of USD 325.37 million in 2024.
• The India Prenatal Genetic Testing Market had a market share of USD 282.93 million in 2024 and is projected to grow at a CAGR of 18.8% during the forecast period. This growth is attributed to several factors, including increasing maternal age, advancements in technology, and rising awareness among both healthcare professionals and the general population regarding the benefits of genetic testing during pregnancy.
• The South Korea Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 16.1% during the forecast period with a market size of USD 235.78 million in 2024.
• The Australia Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 16.7% during the forecast period with a market size of USD 122.60 million in 2024.
• The South East Asia Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 18.0% during the forecast period with a market size of USD 162.69 million in 2024.
• The Rest of Asia Pacific Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 16.8% during the forecast period with a market size of USD 167.40 million in 2024. .

South America Prenatal Genetic Testing

According to Cognitive Market Research, the global Prenatal Genetic Testing Market size was estimated at USD 10251.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 512.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Prenatal Genetic Testing Market size was valued at USD 219.38 million in 2024 and is projected to grow at a CAGR of 15.0% during the forecast period. This growth is attributed to several factors, including increasing maternal age, advancements in technology, and rising awareness among both healthcare professionals and the general population regarding the benefits of genetic testing during pregnancy.
• The Argentina Prenatal Genetic Testing Market had a market share of USD 86.11 million in 2024 and is projected to grow at a CAGR of 15.3% during the forecast period. This growth is attributed to several factors, including increasing maternal age, advancements in technology, and rising awareness among both healthcare professionals and the general population regarding the benefits of genetic testing during pregnancy.
• The Colombia Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 14.2% during the forecast period with a market size of USD 45.62 million in 2024. The Peru Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 14.6% during the forecast period with a market size of USD 42.03 million in 2024.
• The Chile Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 14.7% during the forecast period with a market size of USD 36.90 million in 2024.
• The Rest of Latin America Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 13.5% during the forecast period with a market size of USD 82.52 million in 2024. .

Middle East and Africa Prenatal Genetic Testing

According to Cognitive Market Research, the global Prenatal Genetic Testing Market size was estimated at USD 10251.2 Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 205.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.7% from 2024 to 2031. MEA the Prenatal Genetic Testing Market showcases promising growth prospects driven by factors such as delayed motherhood, leading to an increase in maternal age, which heightens the risk of genetic abnormalities during pregnancy. Moreover, advancements in prenatal testing technologies have improved accuracy and expanded the range of detectable genetic conditions. Additionally, the region has witnessed a growing incidence of genetic disorders, underscoring the necessity for comprehensive prenatal screening and diagnostic services. segmentation analysis sheds light on the prevalent testing approaches adopted within the MEA region. Carrier screening tests, which identify if prospective parents are carriers of specific genetic conditions, have gained significant traction. Furthermore, diagnostic methods, including invasive procedures like amniocentesis and chorionic villus sampling, emerge as dominant categories, reflecting the region's emphasis on accurate diagnosis of genetic abnormalities. In conclusion, MEA's prenatal genetic testing market demonstrates substantial growth potential, buoyed by strong government support, advanced healthcare systems, and increasing demand driven by factors like maternal age and technological advancements.

• The GCC Countries Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 15.5% during the forecast period with a market size of USD 87.75 million in 2024. This growth is attributed to several factors, including increasing maternal age, advancements in technology, and rising awareness among both healthcare professionals and the general population regarding the benefits of genetic testing during pregnancy. The Egypt Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 15.0% during the forecast period with a market size of USD 21.53 million in 2024.
• The South Africa Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 15.7% during the forecast period with a market size of USD 32.39 million in 2024. This growth is attributed to several factors, including increasing maternal age, advancements in technology, and rising awareness among both healthcare professionals and the general population regarding the benefits of genetic testing during pregnancy.
• The Turkey Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 14.2% during the forecast period with a market size of USD 17.63 million in 2024.
• The Nigeria Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 13.8% during the forecast period with a market size of USD 21.53 million in 2024.
• The Rest of MEA Prenatal Genetic Testing Market is projected to witness growth at a CAGR of 13.7% during the forecast period with a market size of USD 24.19 million in 2024. .

Prenatal Genetic Testing Market Analysis

Prenatal Genetic Testing Market Technology Segment Analysis

According to Cognitive Market Research, Diagnostics Methods stands out as the dominating category. Diagnostics methods encompass a range of testing techniques, including non-invasive prenatal testing (NIPT), traditional diagnostic procedures such as amniocentesis and chorionic villus sampling (CVS), and other molecular diagnostic methods. The popularity of diagnostics methods stems from their ability to accurately detect a wide range of genetic disorders and chromosomal abnormalities, providing valuable insights into the health status of the fetus during pregnancy. Additionally, advancements in technology have led to the development of more sophisticated and precise diagnostic tools, enhancing the accuracy and reliability of prenatal genetic testing.

Polymerase Chain Reaction emerges as the fastest-growing category in the Prenatal Genetic Testing Market. PCR technology enables the amplification of specific DNA sequences, allowing for the detection of genetic mutations, chromosomal abnormalities, and other genetic variations with high precision and sensitivity. Its rapid turnaround time, cost-effectiveness, and scalability make it an attractive choice for prenatal genetic testing, particularly in detecting single gene disorders and assessing the risk of inherited conditions. Additionally, PCR-based methods, such as quantitative PCR (qPCR) and digital PCR (dPCR), offer enhanced accuracy and sensitivity, further driving their adoption in prenatal diagnostics.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Prenatal Genetic Testing Industry. Request a Free Sample PDF!

Prenatal Genetic Testing Market Screening Techniques Segment Analysis

According to Cognitive Market Research, the dominating category is Carrier Screening. Carrier screening involves testing individuals, typically prospective parents, for specific genetic mutations associated with inherited conditions, such as cystic fibrosis, sickle cell disease, and Tay-Sachs disease. By identifying carriers of these genetic mutations, healthcare providers can offer counseling and guidance to help couples make informed decisions about family planning and reproductive options. Carrier screening is particularly important in populations with a higher prevalence of certain genetic disorders or in cases where there is a family history of genetic conditions. Its widespread adoption is driven by increasing awareness about the importance of genetic testing in family planning, as well as advancements in technology that have made screening more accessible and cost-effective.

The fastest-growing category in the Prenatal Genetic Testing Market is Sequential Screening. Sequential screening involves a two-step process combining biochemical tests and ultrasound measurements to evaluate the risk of conditions such as Down syndrome, Edwards syndrome, and Patau syndrome. The first step typically includes maternal blood tests to measure specific markers, followed by a detailed ultrasound examination to assess fetal development. If the initial screening indicates an elevated risk, further diagnostic tests, such as amniocentesis or chorionic villus sampling (CVS), may be recommended for confirmation.

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Prenatal Genetic Testing market report 2024 Edition by contacting our team.

Prenatal Genetic Testing Diseases Segment Analysis

Diseases Segment Analysis

According to Cognitive Market Research, the dominating category is Sickle Cell Anemia. Sickle Cell Anemia is an inherited blood disorder characterized by abnormal hemoglobin molecules, leading to red blood cell deformities and various complications. Carrier screening aims to identify individuals who carry a single copy of the mutated gene, typically asymptomatic carriers, and are at risk of passing the disease to their offspring if both parents are carriers. Given the importance of early detection and counseling in preventing the transmission of Sickle Cell Anemia to future generations, carrier screening for this disorder is widely recommended, particularly in regions with a high prevalence of the disease.

The fastest-growing category in the Prenatal Genetic Testing Market is Cystic Fibrosis. Cystic fibrosis is a genetic disorder that affects the respiratory and digestive systems, leading to thick, sticky mucus buildup in the lungs and other organs. Prenatal genetic testing for cystic fibrosis involves screening prospective parents for mutations in the CFTR gene, which is responsible for the condition. With early detection and intervention, expectant parents can make informed decisions about family planning and reproductive options, including the possibility of undergoing in vitro fertilization (IVF) with pre-implantation genetic testing to prevent the transmission of the disease to offspring.

• Alzheimer's Disease
• Cancer
• Cystic Fibrosis
• Sickle Cell Anemia
• Duchenne Muscular Dystrophy
• Thalassemia
• Huntington's Disease
• Rare Diseases
• Other Diseases

Prenatal Genetic Testing End User Segment Analysis

According to Cognitive Market Research, the dominating category is Hospitals. Hospitals provide comprehensive prenatal care, including prenatal genetic testing services, to expectant parents. These services are often offered in collaboration with genetic counselors, obstetricians, and specialized laboratories equipped to perform genetic testing. Hospitals offer a range of prenatal genetic testing options, including non-invasive prenatal testing (NIPT), carrier screening, diagnostic methods like amniocentesis and chorionic villus sampling (CVS), and sequential screening, among others.

The fastest-growing category in the Prenatal Genetic Testing Market is Clinics. Clinics offer a range of prenatal care services, including genetic counseling and testing, making them convenient and accessible options for individuals seeking comprehensive care during pregnancy. With advancements in technology and the availability of non-invasive prenatal testing (NIPT), clinics are able to provide efficient and accurate genetic screening for various chromosomal abnormalities and genetic disorders. Additionally, clinics often collaborate with genetic counselors and specialized laboratories to ensure the quality and reliability of testing results.

• Hospitals
• Clinics
• Diagnostic Centers

Prenatal Genetic Testing Product Segment Analysis

According to Cognitive Market Research, the dominating category is Assay Kits And Reagents. Assay kits and reagents are essential components used in various genetic testing methods, including polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), and microarray analysis, among others. These kits contain pre-measured reagents and materials necessary for conducting specific genetic tests, streamlining the testing process and ensuring consistency and reliability of results. With the increasing demand for prenatal genetic testing, the market for assay kits and reagents is experiencing significant growth, driven by factors such as advancements in technology, expanding applications of genetic testing, and rising awareness among healthcare professionals and expectant parents.

The fastest-growing category in the Prenatal Genetic Testing Market is Disposables, Instruments. Disposables and instruments encompass a wide range of products, including pipettes, microcentrifuge tubes, microarrays, and laboratory equipment used in genetic testing laboratories and clinics. As the demand for prenatal genetic testing continues to rise, there is a growing need for disposable items and instruments that enable accurate sample handling, processing, and analysis. Moreover, advancements in technology have led to the development of innovative disposable devices and instruments that offer enhanced precision, sensitivity, and throughput, further driving their adoption in prenatal genetic testing workflows.

• Consumables
• Assay Kits And Reagents
• Disposables
• Instruments
• Next Generation Sequencing Systems
• Polymerase Chain Reaction Instruments
• Microarrays
• Ultrasound Devices
• Other Instruments
• Services

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion